Collagenase-3 (MMP-13)is expressed by tumor cells in invasive vulvar squamous cell carcinomas

American Journal of Pathology

Volumn 154, Issue 2, 1999, Pages 469-480

  Johansson, Nina ^a   Vaalamo, Maarit ^b   Grénman, Seija ^a   Hietanen, Sakari ^c   Klemi, Pekka ^c   Saarialho Kere, Ulpu ^b   Kähäri, Veli Matti ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c MediCity Research Laboratory ^*

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; COLLAGENASE 3; GELATINASE A; MATRIX METALLOPROTEINASE; MESSENGER RNA; UNCLASSIFIED DRUG;

ARTICLE; CANCER INVASION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; OVARY ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA; VULVA CARCINOMA; WART VIRUS;

EID: 0032963473     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65293-5     Document Type: Article

References (63)

1. Birkedal-Hansen H, Moore WGI, Bodden MK, Windsor LJ, Birkedal-Hansen B, De Carlo A, Engler JA: Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993, 4:197-250
2. Kähäri V-M, Saarialho-Kere U: Matrix metalloproteinases in skin. Exp Dermatol 1997, 6:199-213
3. Stetler-Stevenson WG, Aznavoorian S, Liotta L: Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 1993, 9:541-573
4. Krane SM, Byrne MH, Lemaitre V, Henriet P, Jeffrey JJ, Witter JP, Liu X, Wu H, Jaenisch R, Eeckhout Y: Different collagenase gene products have different roles in degradation of type I collagen. J Biol Chem 1996, 271:28509-28515
5. Freije JMP, Díez-Itza I, Balbín M, Sánchez LM, Blasco R, Tolivia J, López-Otín C: Molecular cloning, and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Chem 1994, 269:16766-16773
6. Knäuper V, López-Otin C, Smith B, Knight G, Murphy G: Biochemical characterization of human collagenase-3. J Biol Chem 1996, 271: 1544-1550
7. Mitchell PG, Magna HA, Reeves LM, Lopresti-Morrow LL, Yocum SA, Rosner PJ, Geoghegan KF, Hambor JE: Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J Clin Invest 1996, 97:761-768
8. Knäuper V, Cowell S, Smith B, López-Otin, C, O'Shea M, Morris H, Zardi L, Murphy G: The role of the C-terminal domain of human collagenase-3 (MMP-13) in activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction. J Biol Chem 1997, 272:7608-7616
9. Fosang AJ, Last K, Knäuper V, Murphy G, Neame PJ: Degradation of cartilage aggrecan by collagenase-3 (MMP-13). FEBS Lett 1996, 380:17-20
10. Johansson N, Saarialho-Kere U, Airola K, Herva R, Nissinen L, Westermarck J, Vuorio E, Heino J, Kähäri V-M: Collagenase-3 (MMP-13) is expressed by hypertrophic chondrocytes, periosteal cells, and osteoblasts during human fetal bone development. Dev Dyn 1997, 208:387-397
11. Ståhle-Bäckdahl M, Sandstedt B, Bruce K, Lindahl A, Jimenez MG, Vega, JA, López-Otín C: Collagenase-3 (MMP-13) is expressed during human fetal ossification and re-expressed in postnatal bone remodeling and in rheumatoid arthritis. Lab Invest 1997, 76:717-728
12. Reboul P, Pelletier J-P, Tardif G, Cloutier J-M, Martel-Pelletier J: The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not synoviocytes. A role in osteoarthritis. J Clin Invest 1996, 97:2011-2019
13. Wernicke D, Seyfert C, Hinzmann B, Gromnica-Ihle E: Cloning of collagenase 3 from synovial membrane and its expression in rheumatoid arthritis and osteoarthritis. J Rheumatol 1996, 23:590-595
14. Lindy O, Konttinen, YT, Sorsa T, Ding Y, Santavirta S, Ceponis A, López-Otín C: Matrix metalloproteinase-13 (collagenase-3) in human rheumatoid synovium. Arthritis Rheum 1997, 40:1391-1399
15. Vaalamo M, Mattila L, Johansson N, Kariniemi A-L, Karjalainen-Lindsberg M-L, Kähäri V-M, Saarialho-Kere U: Distinct populations of stromal cells express collagenase-3 (MMP-13) and collagenase-1 (MMP-1) in chronic ulcers but not in normally healing wounds. J Invest Dermatol 1997, 109:96-101
16. Vaalamo M, Karjalainen-Lindsberg ML, Puolakkainen P, Kere J, Saarialho-Kere U: Distinct expression profiles of stromelysin-2 (MMP-10). collagenase-3 (MMP-13), macrophage metalloelastase (MMP-12), and tissue inhibitor of metalloproteinases-3 (TIMP-3) in intestinal ulcerations. Am J Pathol 1998, 152:1005-1014
17. Uitto V-J, Airola K, Vaalamo M, Johansson N, Putnins E, Firth, JD, Salonen J, López-Otín C, Saarialho-Kere U, Kähäri V-M: Collagenase-3 (matrix metalloproteinase-3) expression is induced in oral mucosal epithelium during chronic inflammation. Am J Pathol 1998, 152:1489-1499
18. Heppner KJ, Matrisian LM, Jenssn RA, Rodgers WH: Expression of most matrix metalloproteinases family members in breast cancer represents a tumor-induced host response. Am J Pathol 1996, 149: 273-282
19. Uría A, Ståhle-Bäckdahl M, Seiki M, Fueyo A, López-Otín C: Regulation of collagenase-3 expression in human breast carcinomas is mediated by stromal-epithelial cell interactions. Cancer Res 1997, 57:4882-4888
20. Johansson N, Airola K, Grenman R, Kariniemi A-L, Saarialho-Kere U, Kähäri V-M: Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck. Am J Pathol 1997, 151:499-508
21. Airola K, Johansson N, Kariniemi A-L, Kahari V-M, Saarialho-Kere U: Human collagenase-3 is expressed in malignant squamous epithelium of the skin. J Invest Dermatol 1997, 109:225-231
22. Uría JA, Balbin M, López JM, Alvarez J, Vizoso F, Takigawa M, López-Otín, C: Collagenase-3 (MMP-13) expression in chondrosarcoma cells and its regulation by basic fibroblast growth factor. Am J Pathol 1998, 153:91-101
23. Johansson N, Westermarck J, Leppä S, Häkkinen L, Koivisto L, López-Otín C, Peltonen J, Heino J, Kähäri V-M: Collagenase-3 (MMP-13) gene expression by HaCaT keratinocytes is enhanced by tumor necrosis factor-α and transforming growth factor-β. Cell Growth Differ 1997, 8:243-250
24. Inoue Y, Abe K, Obata K, Yoshioka T, Ohmura G, Doh K, Yamamoto K, Hoshiai H, Noda K: Immunohistochemical studies on matrix metalloproteinase-9 (MMP-9) and type IV collagen in endometrial carcinoma. J Obstet Gynecol Res 1997, 23:139-145
25. Tamakoshi K, Kikkawa F, Nawa A, Ishikawa H, Mizuno K, Tamakoshi A, Yamagata S, Suganuma N, Tomoda Y: Characterization of extracellular matrix-degrading proteinase and its inhibitor in gynecological cancer tissues with clinically different metastatic form. Cancer 1995, 76:2565-2571
26. Soini Y, Alarakkola E, and Autio-Harmainen H: Expression of messenger RNAs for metalloproteinases 2 and 9. Type IV collagen, and laminin in nonneoplastic and neoplastic endometrium. Hum Pathol 1996, 28:220-226
27. Gilles C, Polette M, Piette J, Munaut C, Thompson EW, Birembaut P, Foidart JM: High level of MT-MMP expression is associated with invasiveness of cervical cancer cells. Int J Cancer 1996, 65:209-213
28. Nuovo GJ, MacConnell PB, Simsir A, Valea F, French DL: Correlation of the in situ detection of polymerase chain reaction-amplified metalloproteinase complementary DNAs and inhibitors with prognosis in cervical carcinoma. Cancer Res 1995, 55:267-275
29. Nuovo GJ: In situ detection of PCR-amplified metalloproteinase cDNAs, their inhibitors, and human papillomavirus transcripts in cervical carcinoma cell lines. Int J Cancer 1997, 71:1056-1060
30. De Nictolis M, Garbisa S, Lucarini G, Goteri G, Masiero L, Ciavattini A, Garzetti GG, Stetler-Stevenson WG, Fabris G, Biagini G, Prat J: 72-kilodalton type IV collagenase, type IV collagen, and Ki 67 antigen in serous tumors of the ovary: a clinicopathologic, immunohistochemical, and serological study. Int J Gynecol Pathol 1996, 15:102-109
31. Moser TL, Young TN, Rodriguez GC, Pizzo SV, Bast RC Jr, Stack MS: Secretion of extracellular matrix-degrading proteinases is increased in epithelial ovarian carcinoma. Int J Cancer 1994, 56:552-559
32. Afzal S, Lalani EN, Poulsom R, Stubbs A, Rowlinson G, Sato H, Seiki M Stamp GWH: MT1-MMP, and MMP-2 mRNA expression in human ovarian tumors: possible implications for the role of desmoplastic fibroblasts. Hum Pathol 1998, 29:155-165
33. Autio-Harmainen H, Karttunen T, Hurskainen T, Höyhtyä M, Kauppila A, and Tryggvason K: Expression of 72 kilodalton type IV collagenase (gelatinase A) in benign and malignant ovarian tumors. Lab Invest 1993, 69:312-321
34. Fishman DA, Bafetti LM, and Stacks MS: Membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation in primary human ovarian epithelial carcinoma cells. Invasion Metastasis 1996, 16:150-159
35. Prosser IW, Stenmark KR, Suthar M, Crouch EC, Mecham RP, Parks WC: Regional heterogeneity of elastin and collagen gene expression in intralobar arteries in response to hypoxic pulmonary hypertension as demonstrated by in situ hybridization. Am J Pathol 1989, 135: 1073-1088
36. Saarialho-Kere UK, Kovacs SO, Pentland AP, Olerud JE, Welgus HG, Parks WC: Cell-matrix interactions modulate interstitial collagenase expression by human keratinocytes actively involved in wound healing. J Clin Invest 1993, 92:2858-2866
37. Saarialho-Kere UK, Pentland AP, Birkedal-Hansen H, Parks WC, Welgus HG: Distinct populations of basal keratinocytes express stromelysin-1 and stromelysin-2 in chronic wounds. J Clin Invest 1994, 94:79-88
38. Nikkari ST, Höyhtyä M, Isola J, Nikkari T: Macrophages contain 92-kd gelatinase (MMP-9) at the site of degenerated internal elastic lamina in temporal arteritis. Am J Pathol 1996, 149:1427-1433
39. Ueno H, Nakamura H, Inoue M, Imai K, Noguchi K, Sato H, Seiki M, Okada Y: Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast cancer. Cancer Res 1997, 57:2055-2060
40. Busiek DF, Ross FP, McDonnell S, Murphy G, Matrisian LM, Welgus HG: The matrix metalloproteinase matrilysin (PUMP) is expressed in developing human mononuclear phagocytes. J Biol Chem 1992, 13:9087-9092
41. Grénman SE, van Dyke DL, Worsham MJ, England B, McClatchey KD, Hopkins M, Babu VR, Grénman R, Carey T: Phenotypic characterization, karyotype analysis and in vitro tamoxifen sensitivity of new ER-negative vulvar carcinoma cell lines, UM-SCV-1A and UM-SCV-1B. Int J Cancer 1990, 45:920-927
42. Worsham M, van Dyke D, Grénman S, Grénman R, Hopkins M, Roberts J, Gasser K, Schwartz DR, Carey T: Consistent chromosomal abnormalities in squamous carcinoma of the vulva. Genes Chromosomes Cancer 1991, 3:420-432
43. Rantanen V, Grénman S, Kurvinen K, Hietanen S, Raitanen M, Syrjänen S: p53 mutations and presence of HPV DNA does not correlate with radiosensitivity of gynecological cancer cell lines Gynecol Oncol 1998, 71:352-358
44. Rantanen V, Grénman S, Kulmala J, Grénman R: The intrinsic radiosensitivity and sublethal damage repair capacity of five cervical carcinoma cell lines tested with the 96-well-plate assay. J Cancer Res Clin Oncol 1995, 121:230-234
45. Rantanen V, Grénman S, Kulmala J, Grénman R: Comparative evaluation of cisplatin and carboplatin sensitivity in endometrial adenocarcinoma cell lines. Br J Cancer 1994, 69:482-486
46. Hietanen S, Kurvinen K, Syrjänen K, Grénman S, Carey T, McClatchey K, Syrjänen S: Mutation of tumor suppressor gene p53 is frequently found in vulvar carcinoma cells. Am J Obstet Gynecol 1995, 173:1477-1482
47. Hietanen S, Grénman S, Syrjänen K, Lappalainen K, Kauppinen J, Carey T, Syrjänen S: Human papillomavirus in vulvar and vaginal carcinoma cell lines. Br J Cancer 1995, 72:134-139
48. Hietanen S, Auvinen E, Grénman S, Lakkala T, Sajantila A, Klemi P, Mäenpää J: Isolation of two keratinocyte cell lines derived from HPV-positive dysplastic vaginal lesions. Int J Cancer 1992, 52:391-398
49. Hietanen S, Syrjänen K, Syrjänen S: Characterization of keratin and cell cycle protein expression in cell lines from squamous intraepithelial lesions progressing towards a malignant phenotype. Br J Cancer 1998, 77:766-775
50. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159
51. Goldberg GI, Wilhelm SM, Kronberger A, Bauer EA, Grant GA, Eisen AZ: Human fibroblast collagenase. Complete primary structure and homology to an oncogene transformation-induced rat protein. J Biol Chem 1986, 261:6600-6605
52. Saus J, Quinones S, Otani Y, Nagase H, Harris E D Jr., Kurkinen M: The complete structure of human matrix metalloproteinase-3. J Biol Chem 1988, 263:6742-6747
53. Collier IE, Wilhelm SM, Eisen AZ, Marmer BL, Grant GA, Seltzer JL, Kronberger A, He CS, Bauer EA, Goldberg GI: H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J Biol Chem 1988, 263:6579-6587
54. Wilhelm SM, Collier IE, Marmer BL, Eisen AZ, Grant GA, Goldberg GI: SV40-transformed human lung fibroblasts secrete a 92-kd type IV collagenase which is identical to that secreted by normal macrophages: J Biol Chem 1989, 264:17213-17221
55. Lohi J, Lehti K, Westermarck J, Kähäri V-M, Keski-Oja J: Regulation of membrane type metalloproteinase-1 expression by growth factors and phorbol 12-myristate 13-acetate. Eur J Biochem 1996, 239: 239-247
56. Quantin B, Murphy G, Breatnach R: Pump-1 cDNA codes for a protein with characteristics similar to those of classical collagenase family members. Biochemistry 1989, 28:5327-5334
57. Fort P, Marly L, Piechaczyk M, El Sabrouty S, Dani C, Jeanteur P, Blanchard JM: Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res 1985, 13:1431-1441
58. Knäuper V, Will H, López-Otín C, Smith B, Atkinson SJ, Stanton H, Hembry RM, Murphy G: Cellular mechanisms for human procollagenase-3 activation Evidence that MT1-MMP (MMP-14) and gelatinase A (MMP-2) are able to generate active enzyme. J Biol Chem 1996, 271:17124-17131
59. Knäuper V, Smith B, López-Otín C, Murphy G: Activation of progelatinase B (proMMP-9) by active collagenase-3 (MMP-13). Eur J Biochem 1997, 248:369-373
60. Pyke C, Ralfkiaer E, Huhtala P, Hurskainen T, Dano K, Tryggvason K: Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization. Cancer Res 1992, 52:1336-1341
61. Okada A, Bellocq JP, Royer N, Chenard MP, Rio MC, Chambon P, Basset P: Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc Nat Acad Sci USA 1995, 92:2730-2734
62. Yoshizaki T, Sato H, Maruyama Y, Murono S, Furukawa M, Park CS, Seiki M: Increased expression of membrane type 1-matrix metalloproteinase in head and neck carcinoma. Cancer 1997, 79:139-144
63. Ståhle-Bäckdahl M, Parks WC: 92-kd gelatinase is actively expressed by eosinophils and stored by neutrophils in squamous cell carcinoma. Am J Pathol 1993, 142:995-1000